A Population-Based study to evaluate the severity of chronic obstructive pulmonary disease (COPD) in new users of aclidinium and other COPD medications in the United Kingdom (UK) and Denmark.

Trial Profile

A Population-Based study to evaluate the severity of chronic obstructive pulmonary disease (COPD) in new users of aclidinium and other COPD medications in the United Kingdom (UK) and Denmark.

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Sep 2017

At a glance

  • Drugs Aclidinium bromide (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Sep 2017 New trial record
    • 30 Aug 2017 Results presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top